AAAAAA

   
Results: 1-23 |
Results: 23

Authors: Grossmann, ME Huang, HJ Tindall, DJ
Citation: Me. Grossmann et al., Androgen receptor signaling in androgen-refractory prostate cancer, J NAT CANC, 93(22), 2001, pp. 1687-1697

Authors: Xie, XM Zhao, XQ Liu, YF Young, CYF Tindall, DJ Slawin, KM Spencer, DM
Citation: Xm. Xie et al., Robust prostate-specific expression for targeted gene therapy based on thehuman kallikrein 2 promoter, HUM GENE TH, 12(5), 2001, pp. 549-561

Authors: Spitzweg, C Dietz, AB O'Connor, MK Bergert, ER Tindall, DJ Young, CYF Morris, JC
Citation: C. Spitzweg et al., In vivo sodium iodide symporter gene therapy of prostate cancer, GENE THER, 8(20), 2001, pp. 1524-1531

Authors: Tindall, DJ Scardino, PJ
Citation: Dj. Tindall et Pj. Scardino, State of research for prostate cancer: Excerpt from the report of the Prostate Cancer Progress Review Group, UROLOGY, 57(4A), 2001, pp. 28-30

Authors: Huang, H Cheville, JC Pan, YQ Roche, PC Schmidt, LJ Tindall, DJ
Citation: H. Huang et al., PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression, J BIOL CHEM, 276(42), 2001, pp. 38830-38836

Authors: Murillo, H Huang, HJ Schmidt, LJ Smith, DI Tindall, DJ
Citation: H. Murillo et al., Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state, ENDOCRINOL, 142(11), 2001, pp. 4795-4805

Authors: Murillo, H Schmidt, LJ Tindall, DJ
Citation: H. Murillo et al., Tyrphostin AGS25 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2, CANCER RES, 61(20), 2001, pp. 7408-7412

Authors: Mora, GR Tindall, DJ
Citation: Gr. Mora et Dj. Tindall, Ligand dependent and independent activation of the androgen receptor, CONT CANC R, 2001, pp. 219-239

Authors: Butler, R Mitchell, SH Tindall, DJ Young, CYF
Citation: R. Butler et al., Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-Delta(12,14)-prostaglandin J(2), CELL GROWTH, 11(1), 2000, pp. 49-61

Authors: Liu, WG Mai, M Yokomizo, A Qian, CP Tindall, DJ Smith, DI Thibodeau, SN
Citation: Wg. Liu et al., Differential expression and allelotyping of the p73 gene in neuroblastoma, INT J ONCOL, 16(1), 2000, pp. 181-185

Authors: Slawin, KM Shariat, SF Nguyen, C Leventis, AK Song, WT Kattan, HW Young, CYF Tindall, DJ Wheeler, TM
Citation: Km. Slawin et al., Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein, CANCER RES, 60(24), 2000, pp. 7142-7148

Authors: Spitzweg, C O'Connor, MK Bergert, ER Tindall, DJ Young, CYF Morris, JC
Citation: C. Spitzweg et al., Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter, CANCER RES, 60(22), 2000, pp. 6526-6530

Authors: Black, MH Magklara, A Obiezu, C Levesque, MA Sutherland, DJA Tindall, DJ Young, CYF Sauter, ER Diamandis, EP
Citation: Mh. Black et al., Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions, BR J CANC, 82(2), 2000, pp. 361-367

Authors: Yokomizo, A Mai, M Tindall, DJ Cheng, L Bostwick, DG Naito, S Smith, DI Liu, WG
Citation: A. Yokomizo et al., Overexpression of the wild type p73 gene in human bladder cancer, ONCOGENE, 18(8), 1999, pp. 1629-1633

Authors: Yokomizo, A Mai, M Bostwick, DG Tindall, DJ Qian, JQ Cheng, L Jenkins, RB Smith, DI Liu, WG
Citation: A. Yokomizo et al., Mutation and expression analysis of the p73 gene in prostate cancer, PROSTATE, 39(2), 1999, pp. 94-100

Authors: Tindall, DJ Scardino, PT
Citation: Dj. Tindall et Pt. Scardino, Defeating prostate cancer: Crucial directions for research-excerpt from the report of the prostate cancer progress review group, PROSTATE, 38(2), 1999, pp. 166-171

Authors: Charlesworth, MC Young, CYE Miller, VM Tindall, DJ
Citation: Mc. Charlesworth et al., Kininogenase activity of prostate-derived human glandular kallikrein (hK2)purified from seminal fluid, J ANDROLOGY, 20(2), 1999, pp. 220-229

Authors: Partin, AW Catalona, WJ Finlay, JA Darte, C Tindall, DJ Young, CYF Klee, GG Chan, DW Rittenhouse, HG Wolfert, RL Woodrum, DL
Citation: Aw. Partin et al., Use of human glandular kallikrein 2 for the detection of prostate cancer: Preliminary analysis, UROLOGY, 54(5), 1999, pp. 839-845

Authors: Darson, MF Pacelli, A Roche, P Ritttenhouse, HG Wolfert, RL Saeid, MS Young, CYF Klee, GG Tindall, DJ Bostwick, DG
Citation: Mf. Darson et al., Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases, UROLOGY, 53(5), 1999, pp. 939-944

Authors: Zhang, SB Hsieh, ML Zhu, W Klee, GG Tindall, DJ Young, CYF
Citation: Sb. Zhang et al., Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression, ENDOCRINOL, 140(4), 1999, pp. 1665-1671

Authors: Klee, GG Goodmanson, MK Jacobsen, SJ Young, CYF Finlay, JA Rittenhouse, HG Wolfert, RL Tindall, DJ
Citation: Gg. Klee et al., Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2, CLIN CHEM, 45(6), 1999, pp. 800-806

Authors: Spitzweg, C Zhang, SB Bergert, ER Castro, MR McIver, B Heufelder, AE Tindall, DJ Young, CYF Morris, JC
Citation: C. Spitzweg et al., Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines, CANCER RES, 59(9), 1999, pp. 2136-2141

Authors: Mikolajczyk, SD Millar, LS Marker, KM Rittenhouse, HG Wolfert, RL Marks, LS Charlesworth, MC Tindall, DJ
Citation: Sd. Mikolajczyk et al., Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue, CANCER RES, 59(16), 1999, pp. 3927-3930
Risultati: 1-23 |